Skip to main content
Log in

Clinical Trial Report: Is It Safe to Continue Anticoagulation Therapy in Patients with Infective Endocarditis?

  • Clinical Trial Report
  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Anavekar NS, Tleyjeh IM, Mirzoyev Z, et al.: Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis. Clin Infect Dis 2007, 44:1180–1186.

    Article  PubMed  Google Scholar 

  2. Nicolau DP, Freeman CD, Nightingale CH, et al.: Reduction of bacterial titers by low-dose aspirin in experimental aortic valve endocarditis. Infect Immun 1993, 61:1593–1595.

    CAS  PubMed  Google Scholar 

  3. Nicolau DP, Marangos MN, Nightingale CH, Quintiliani R: Influence of aspirin on development and treatment of experimental Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 1995, 39:1748–1751.

    CAS  PubMed  Google Scholar 

  4. Chan KL, Dumesnil JG, Cujec B, et al.: A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol 2003, 42:775–780.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Donald P. Levine.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Levine, D.P. Clinical Trial Report: Is It Safe to Continue Anticoagulation Therapy in Patients with Infective Endocarditis?. Curr Infect Dis Rep 12, 231–233 (2010). https://doi.org/10.1007/s11908-010-0109-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-010-0109-0

Keywords

Navigation